Cholinergic signaling in the hippocampus regulates social stress resilience and anxiety- and depression-like behavior

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 9, 2013, Pages 3573-3578

  Mineur, Yann S ^a   Obayemi, Adetokunbo ^a   Wigestrand, Mattis B ^a   Fote, Gianna M ^a   Calarco, Cali A ^a   Li, Alice M ^a   Picciotto, Marina R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Affective disorders; Psychosocial stress

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; FLUOXETINE; MECAMYLAMINE; PHYSOSTIGMINE; SCOPOLAMINE; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; BEHAVIOR CHANGE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; COPING BEHAVIOR; DEPRESSION; DRUG EFFECT; ENZYME ACTIVITY; GENE SILENCING; HIPPOCAMPUS; HYPOTHESIS; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SOCIAL STRESS; TRANSGENE;

ACETYLCHOLINESTERASE; ANIMALS; ANTIDEPRESSIVE AGENTS; ANXIETY; BEHAVIOR, ANIMAL; CHOLINERGIC ANTAGONISTS; CHOLINERGIC NEURONS; DEPENDOVIRUS; DEPRESSION; FLUOXETINE; GENE KNOCKDOWN TECHNIQUES; HINDLIMB SUSPENSION; HIPPOCAMPUS; HUMANS; MALE; MICE; MICE, INBRED C57BL; PHENOTYPE; PHYSOSTIGMINE; RECEPTORS, CHOLINERGIC; RESILIENCE, PSYCHOLOGICAL; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL; TIME FACTORS;

EID: 84874506923     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1219731110     Document Type: Article

References (45)

1. Saricicek A, et al. (2012) Persistent β2-nicotinic acetylcholinergic receptor dysfunction in major depressive disorder. Am J Psychiatry 169(8): 851-859.
2. Furey ML, Drevets WC (2006) Antidepressant efficacy of the antimuscarinic drug scopolamine: A randomized, placebo-controlled clinical trial. Arch Gen Psychiatry 63(10): 1121-1129.
3. Janowsky DS (2011) Serendipity strikes again: Scopolamine as an antidepressant agent in bipolar depressed patients. Curr Psychiatry Rep 13(6): 443-445.
4. Mineur YS, Picciotto MR (2010) Nicotine receptors and depression: Revisiting and revising the cholinergic hypothesis. Trends Pharmacol Sci 31(12): 580-586.
5. Janowsky DS, el-Yousef MK, Davis JM, Sekerke HJ (1972) A cholinergic-adrenergic hypothesis of mania and depression. Lancet 2(7778): 632-635.
6. Risch SC, et al. (1981) Physostigmine induction of depressive symptomatology in normal human subjects. Psychiatry Res 4(1): 89-94.
7. Dilsaver SC, Peck JA, Overstreet DH (1992) The Flinders Sensitive Line exhibits enhanced thermic responsiveness to nicotine relative to the Sprague-Dawley rat. Pharmacol Biochem Behav 41(1): 23-27.
8. Caspi A, et al. (2003) Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science 301(5631): 386-389.
9. Meerson A, et al. (2010) Changes in brain MicroRNAs contribute to cholinergic stress reactions. J Mol Neurosci 40(1-2): 47-55.
10. Hrabovska A, Duysen EG, Sanders JD, Murrin LC, Lockridge O (2005) Delivery of human acetylcholinesterase by adeno-associated virus to the acetylcholinesterase knockout mouse. Chem Biol Interact 157-158: 71-78.
11. Camp S, et al. (2010) Contributions of selective knockout studies to understanding cholinesterase disposition and function. Chem Biol Interact 187(1-3): 72-77.
12. Meshorer E, et al. (2002) Alternative splicing and neuritic mRNA translocation under long-term neuronal hypersensitivity. Science 295(5554): 508-512.
13. Sternfeld M, et al. (2000) Excess "read-through" acetylcholinesterase attenuates but the "synaptic" variant intensifies neurodeterioration correlates. Proc Natl Acad Sci USA 97(15): 8647-8652.
14. Salas R, et al. (2008) Nicotine relieves anxiogenic-like behavior in mice that overexpress the read-through variant of acetylcholinesterase but not in wild-type mice. Mol Pharmacol 74(6): 1641-1648.
15. Cryan JF, Mombereau C, Vassout A (2005) The tail suspension test as a model for assessing antidepressant activity: Review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 29(4-5): 571-625.
16. Berton O, et al. (2006) Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311(5762): 864-868.
17. Vialou V, et al. (2010) DeltaFosB in brain reward circuits mediates resilience to stress and antidepressant responses. Nat Neurosci 13(6): 745-752.
18. Krishnan V, Nestler EJ (2010) Linking molecules to mood: New insight into the biology of depression. Am J Psychiatry 167(11): 1305-1320.
19. Picciotto MR, Higley MJ, Mineur YS (2012) Acetylcholine as a neuromodulator: Cholinergic signaling shapes nervous system function and behavior. Neuron 76(1): 116-129.
20. Mark GP, Rada PV, Shors TJ (1996) Inescapable stress enhances extracellular acetylcholine in the rat hippocampus and prefrontal cortex but not the nucleus accumbens or amygdala. Neuroscience 74(3): 767-774.
21. Sarter M, Parikh V, Howe WM (2009) Phasic acetylcholine release and the volume transmission hypothesis: Time to move on. Nat Rev Neurosci 10(5): 383-390.
22. George TP, Sacco KA, Vessicchio JC, Weinberger AH, Shytle RD (2008) Nicotinic antagonist augmentation of selective serotonin reuptake inhibitor-refractory major depressive disorder: A preliminary study. J Clin Psychopharmacol 28(3): 340-344.
23. Mineur YS, Somenzi O, Picciotto MR (2007) Cytisine, a partial agonist of high-affinity nicotinic acetylcholine receptors, has antidepressant-like properties in male C57BL/6J mice. Neuropharmacology 52(5): 1256-1262.
24. Kaufer D, Friedman A, Seidman S, Soreq H (1999) Anticholinesterases induce multigenic transcriptional feedback response suppressing cholinergic neurotransmission. Chem Biol Interact 119-120: 349-360.
25. Mesulam MM (1995) Cholinergic pathways and the ascending reticular activating system of the human brain. Ann N Y Acad Sci 757: 169-179.
26. Warner-Schmidt JL, et al. (2012) Cholinergic interneurons in the nucleus accumbens regulate depression-like behavior. Proc Natl Acad Sci USA 109(28): 11360-11365.
27. Kaufer D, Friedman A, Seidman S, Soreq H (1998) Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature 393(6683): 373-377.
28. Gilad GM (1987) The stress-induced response of the septo-hippocampal cholinergic system. A vectorial outcome of psychoneuroendocrinological interactions. Psychoneuroendocrinology 12(3): 167-184.
29. Cobb SR, Davies CH (2005) Cholinergic modulation of hippocampal cells and circuits. J Physiol 562(Pt 1): 81-88.
30. Soreq H, Seidman S (2001) Acetylcholinesterase: New roles for an old actor. Nat Rev Neurosci 2(4): 294-302.
31. Shohami E, et al. (2000) Antisense prevention of neuronal damages following head injury in mice. J Mol Med (Berl) 78(4): 228-236.
32. Smythe JW, Bhatnagar S, Murphy D, Timothy C, Costall B (1998) The effects of intrahippocampal scopolamine infusions on anxiety in rats as measured by the blackwhite box test. Brain Res Bull 45(1): 89-93.
33. Martinowich K, et al. (2012) Roles of p75(NTR), long-term depression, and cholinergic transmission in anxiety and acute stress coping. Biol Psychiatry 71(1): 75-83.
34. Overstreet DH (1993) The Flinders sensitive line rats: A genetic animal model of depression. Neurosci Biobehav Rev 17(1): 51-68.
35. Hasey G, Hanin I (1991) The cholinergic-adrenergic hypothesis of depression reexamined using clonidine, metoprolol, and physostigmine in an animal model. Biol Psychiatry 29(2): 127-138.
36. File SE, Kenny PJ, Cheeta S (2000) The role of the dorsal hippocampal serotonergic and cholinergic systems in themodulation of anxiety. Pharmacol BiochemBehav 66(1): 65-72.
37. Tucci S, Cheeta S, Seth P, File SE (2003) Corticotropin releasing factor antagonist, alpha- helical CRF(9-41), reverses nicotine-induced conditioned, but not unconditioned, anxiety. Psychopharmacology (Berl) 167(3): 251-256.
38. File SE, Gonzalez LE, Andrews N (1998) Endogenous acetylcholine in the dorsal hippocampus reduces anxiety through actions on nicotinic and muscarinic1 receptors. Behav Neurosci 112(2): 352-359.
39. Andrä J, Lojda Z (1986) A histochemical method for the demonstration of acetylcholinesterase activity using semipermeable membranes. Histochemistry 84(4-6): 575-579.
40. Karnovsky MJ, Roots L (1964) A "direct-coloring" thiocholine method for cholinesterases. J Histochem Cytochem 12: 219-221.
41. Mineur YS, et al. (2011) Nicotine decreases food intake through activation of POMC neurons. Science 332(6035): 1330-1332.
42. Mineur YS, et al. (2011) α4β2 nicotinic acetylcholine receptor partial agonists with low intrinsic efficacy have antidepressant-like properties. Behav Pharmacol 22(4): 291-299.
43. Krishnan V, et al. (2007) Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 131(2): 391-404.
44. Kudryavtseva NN, Bakshtanovskaya IV, Koryakina LA (1991) Social model of depression in mice of C57BL/6J strain. Pharmacol Biochem Behav 38(2): 315-320.
45. Wilkinson MB, et al. (2011) A novel role of the WNT-dishevelled- GSK3β signaling cascade in the mouse nucleus accumbens in a social defeat model of depression. J Neurosci 31(25): 9084-9092.